Brief: Ondine Biomedical H1 Revenue USD 1.01 Million
26/09/2025 07:00
Sep 26 (Reuters) - Ondine Biomedical H1 EBIT USD -12.5 million.
Recent news on Ondine Biomedical
See all newsBrief: Ondine Lantern Phase 3 Database Lock Expected Within A Week; Top-Line Results In 1-2 Weeks
Ondine Biomedical - Leeds Drops SSIs by 78.5% in Complex Brain Surgery
Brief: Ondine Biomedical Expects 2026 To Be A Defining Year For Company
Ondine Biomedical - Notice of AGM
Ondine Biomedical - 2025 Full Year Results and Annual Report